A novel transgenic zebrafish model for blood-brain and blood-retinal barrier development

被引:169
作者
Xie, Jing [1 ]
Farage, Eric [1 ]
Sugimoto, Masahiko [1 ]
Anand-Apte, Bela [1 ,2 ]
机构
[1] Cleveland Clin, Cole Eye Inst, Dept Ophthalm, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA
来源
BMC DEVELOPMENTAL BIOLOGY | 2010年 / 10卷
关键词
ASTROCYTE-ENDOTHELIAL INTERACTIONS; VASCULAR-PERMEABILITY; EXPRESSION; BRADYKININ; PHOSPHORYLATION; VERTEBRATES; MECHANISMS; JUNCTIONS; INTEGRITY; OCCLUDIN;
D O I
10.1186/1471-213X-10-76
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Development and maintenance of the blood-brain and blood-retinal barrier is critical for the homeostasis of brain and retinal tissue. Despite decades of research our knowledge of the formation and maintenance of the blood-brain (BBB) and blood-retinal (BRB) barrier is very limited. We have established an in vivo model to study the development and maintenance of these barriers by generating a transgenic zebrafish line that expresses a vitamin D-binding protein fused with enhanced green fluorescent protein (DBP-EGFP) in blood plasma, as an endogenous tracer. Results: The temporal establishment of the BBB and BRB was examined using this transgenic line and the results were compared with that obtained by injection of fluorescent dyes into the sinus venosus of embryos at various stages of development. We also examined the expression of claudin-5, a component of tight junctions during the first 4 days of development. We observed that the BBB of zebrafish starts to develop by 3 dpf, with expression of claudin-5 in the central arteries preceding it at 2 dpf. The hyaloid vasculature in the zebrafish retina develops a barrier function at 3 dpf, which endows the zebrafish with unique advantages for studying the BRB. Conclusion: Zebrafish embryos develop BBB and BRB function simultaneously by 3 dpf, which is regulated by tight junction proteins. The Tg(l-fabp: DBP-EGFP) zebrafish will have great advantages in studying development and maintenance of the blood-neural barrier, which is a new application for the widely used vertebrate model.
引用
收藏
页数:14
相关论文
共 52 条
  • [31] Wnt/β-catenin signaling controls development of the blood-brain barrier
    Liebner, Stefan
    Corada, Monica
    Bangsow, Thorsten
    Babbage, Jane
    Taddei, Andrea
    Czupalla, Cathrin J.
    Reis, Marco
    Felici, Angelina
    Wolburg, Hartwig
    Fruttiger, Marcus
    Taketo, Makoto M.
    von Melchner, Harald
    Plate, Karl Heinz
    Gerhardt, Holger
    Dejana, Elisabetta
    [J]. JOURNAL OF CELL BIOLOGY, 2008, 183 (03) : 409 - 417
  • [32] SYNTHESIS AND LOCALIZATION OF PLASMA-PROTEINS IN THE DEVELOPING HUMAN-BRAIN - INTEGRITY OF THE FETAL BLOOD-BRAIN BARRIER TO ENDOGENOUS PROTEINS OF HEPATIC ORIGIN
    MOLLGARD, K
    DZIEGIELEWSKA, KM
    SAUNDERS, NR
    ZAKUT, H
    SOREQ, H
    [J]. DEVELOPMENTAL BIOLOGY, 1988, 128 (01) : 207 - 221
  • [33] Roles of ZO-1, occludin, and actin in oxidant-induced barrier disruption
    Musch, MW
    Walsh-Reitz, MM
    Chang, EB
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2006, 290 (02): : G222 - G231
  • [34] Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes
    Navaratna, Deepti
    McGuire, Paul G.
    Menicucci, Gina
    Das, Arup
    [J]. DIABETES, 2007, 56 (09) : 2380 - 2387
  • [35] Strategies to advance translational research into brain barriers
    Neuwelt, Edward
    Abbott, Njoan
    Abrey, Lauren
    Banks, William A.
    Blakley, Brian
    Davis, Thomas
    Engelhardt, Britta
    Grammas, Paula
    Nedergaard, Maiken
    Nutt, John
    Pardridge, William
    Rosenberg, Gary A.
    Smith, Quentin
    Drewes, Lester R.
    [J]. LANCET NEUROLOGY, 2008, 7 (01) : 84 - 96
  • [36] Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice
    Nitta, T
    Hata, M
    Gotoh, S
    Seo, Y
    Sasaki, H
    Hashimoto, N
    Furuse, M
    Tsukita, S
    [J]. JOURNAL OF CELL BIOLOGY, 2003, 161 (03) : 653 - 660
  • [37] Brain drug development and brain drug targeting
    Pardridge, William M.
    [J]. PHARMACEUTICAL RESEARCH, 2007, 24 (09) : 1729 - 1732
  • [38] Plasma Kallikrein Mediates Angiotensin II Type 1 Receptor-Stimulated Retinal Vascular Permeability
    Phipps, Joanna A.
    Clermont, Allen C.
    Sinha, Sukanto
    Chilcote, Tamie J.
    Bursell, Sven-Erik
    Feener, Edward P.
    [J]. HYPERTENSION, 2009, 53 (02) : 175 - U127
  • [39] REGOLI D, 1980, PHARMACOL REV, V32, P1
  • [40] Characterization of vascular mural cells during zebrafish development
    Santoro, Massimo M.
    Pesce, Gabriella
    Stainier, Didier Y.
    [J]. MECHANISMS OF DEVELOPMENT, 2009, 126 (8-9) : 638 - 649